Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ra'anana, Israel
SEC filing record 1 source field available
Fiscal year end
31 December
UroGen Pharma Ltd. has filed 577 SEC EDGAR filings since 04 Mar 2016

SEC filing history

Showing 126-150 of 577 matching filings.

Per page
25
Current page
6
3

3 filing

Filing date
09 Oct 2024
Reporting date
08 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Sep 2024
Reporting date
09 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Sep 2024
Reporting date
09 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Sep 2024
Reporting date
09 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38079

144 filing

Filing date
10 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-281520

FORM S-8

Filing date
13 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Aug 2024
Reporting date
06 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Aug 2024
Reporting date
06 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Aug 2024
Reporting date
06 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Aug 2024
Reporting date
06 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Aug 2024
Reporting date
06 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Aug 2024
Reporting date
06 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Aug 2024
Reporting date
06 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38079

ARS filing

Filing date
09 Jul 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38079

FORM DEFA14A

Filing date
01 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38079

FORM DEF 14A

Filing date
01 Jul 2024
Reporting date
07 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89992

COWEN AND COMPANY, LLC

Filing date
24 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89992

UROGEN PHARMA LTD.

Filing date
24 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .